Antifungal agent | MIC range (μg/mL) | No. (%) of isolates indicated susceptibility category by CBPs | |||
---|---|---|---|---|---|
S | S-DD | R | |||
Fluconazole | 0.06–2 | 32(100) | 0 | 0 | |
0.06–64 | 13(93) | 0 | 1(7) | ||
0.125–4 | 12(100) | 0 | 0 | ||
0.375–4 | 4(100) | 0 | 0 | ||
1–1 | 1 (100) | 0 | 0 | ||
Voriconazole | 0.06–2 | 29(91) | 3(9) | 0 | |
0.03–1 | 11(79) | 2(14) | 1(7) | ||
0.06–1 | 12(100) | 0 | 0 | ||
1–4 | 2(50) | 1(25) | 1(25) | ||
0.5–0.5 | 1 (100) | 0 | 0 |
Method | Category | Fluconazole by BMD | No. of strains | Total agreement (%) | Voriconazole by BMD | No. of strains | Total agreement (%) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
S | I | R | VME | ME | mE | S | I | R | VME | ME | mE | ||||
S | 61 | 0 | 0 | 0 | 0 | 1 | 98 | 54 | 2 | 0 | 0 | 0 | 5 | 92 | |
I | 1 | 0 | 0 | 1 | 4 | 2 | |||||||||
R | 0 | 0 | 1 | 0 | 0 | 0 | |||||||||
S | 57 | 0 | 0 | 0 | 1 | 4 | 92 | 55 | 1 | 0 | 0 | 0 | 1 | 98 | |
I | 4 | 0 | 0 | 0 | 5 | 0 | |||||||||
R | 1 | 0 | 1 | 0 | 0 | 2 |